Page last updated: 2024-08-16

salmeterol xinafoate and Tricuspid Incompetence

salmeterol xinafoate has been researched along with Tricuspid Incompetence in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bosotti, L; Carlucci, P; Cazzola, M; Centanni, S; Mantero, A; Mondoni, M; Santus, P1

Trials

1 trial(s) available for salmeterol xinafoate and Tricuspid Incompetence

ArticleYear
Doppler echocardiographic assessment of the effects of inhaled long-acting beta2-agonists on pulmonary artery pressure in COPD patients.
    Pulmonary pharmacology & therapeutics, 2007, Volume: 20, Issue:3

    Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Aged; Aged, 80 and over; Albuterol; Blood Pressure; Double-Blind Method; Echocardiography, Doppler; Ethanolamines; Forced Expiratory Volume; Formoterol Fumarate; Heart Rate; Humans; Middle Aged; Pilot Projects; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate; Treatment Outcome; Tricuspid Valve Insufficiency

2007